Cardinal Health, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Cardinal Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- Cardinal Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-12-31 was 0.00 shares.
- Cardinal Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-09-30 was 0.00 shares.
- Cardinal Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- Cardinal Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 1.00M shares, a 0.00% change from fiscal 2020.
- Cardinal Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 1.00M shares.
- Cardinal Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 0.00 shares, a 100.00% decline from fiscal 2018.
- Cardinal Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2018 was 1.00M shares, a 50.00% decline from fiscal 2017.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2022-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-05 | 0.00 shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-03 | 1.00M shares derived: sum of 4 quarters · filed 2022-02-03 |
| 2021-09-30 | 0.00 shares 10-Q · filed 2021-11-09 | 1.00M shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-16 | 1.00M shares 10-K · filed 2021-08-16 |
| 2021-03-31 | 1.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-06 | 2.00M shares derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-05 | 1.00M shares derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-09-30 | 0.00 shares 10-Q · filed 2020-11-05 | 1.00M shares derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-06-30 | 1.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-16 | 1.00M shares 10-K · filed 2021-08-16 |
| 2020-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | 0.00 shares derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | 0.00 shares derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-09-30 | 0.00 shares 10-Q · filed 2019-11-07 | 0.00 shares derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-13 | 0.00 shares 10-K · filed 2020-08-13 |
| 2019-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-09 | 0.00 shares derived: sum of 4 quarters · filed 2019-08-20 |
| 2018-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07 | 1.00M shares derived: sum of 4 quarters · filed 2019-08-20 |
| 2018-09-30 | 0.00 shares 10-Q · filed 2018-11-08 | 1.00M shares derived: sum of 4 quarters · filed 2019-08-20 |
| 2018-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-20 | 1.00M shares 10-K · filed 2019-08-20 |
| 2018-03-31 | 1.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | 2.00M shares derived: sum of 4 quarters · filed 2018-08-22 |
| 2017-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | 1.00M shares derived: sum of 4 quarters · filed 2018-08-22 |
| 2017-09-30 | 0.00 shares 10-Q · filed 2017-11-07 | 1.00M shares derived: sum of 4 quarters · filed 2018-08-22 |
| 2017-06-30 | 1.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-22 | 2.00M shares 10-K · filed 2018-08-22 |
| 2017-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-02 | 2.00M shares derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-07 | 2.00M shares derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-09-30 | 1.00M shares 10-Q · filed 2016-11-02 | 2.00M shares derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-06-30 | 1.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-10 | 2.00M shares 10-K · filed 2017-08-10 |
| 2016-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-03 | 1.00M shares derived: sum of 4 quarters · filed 2016-08-12 |
| 2015-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-02 | 2.00M shares derived: sum of 4 quarters · filed 2016-08-12 |
| 2015-09-30 | 1.00M shares 10-Q · filed 2015-11-03 | 2.00M shares derived: sum of 4 quarters · filed 2016-08-12 |
| 2015-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-12 | 3.00M shares 10-K · filed 2016-08-12 |
| 2015-03-31 | 1.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-05 | 3.00M shares derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-03 | 5.00M shares derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-09-30 | 2.00M shares 10-Q · filed 2014-11-05 | 6.00M shares derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-13 | 7.00M shares 10-K · filed 2015-08-13 |
| 2014-03-31 | 3.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-06 | 10.00M shares derived: sum of 4 quarters · filed 2014-08-13 |
| 2013-12-31 | 1.00M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-06 | 9.00M shares derived: sum of 4 quarters · filed 2014-08-13 |
| 2013-09-30 | 3.00M shares 10-Q · filed 2013-11-07 | 8.00M shares derived: sum of 4 quarters · filed 2014-08-13 |
| 2013-06-30 | 3.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-13 | 6.00M shares 10-K · filed 2014-08-13 |
| 2013-03-31 | 2.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | 3.60M shares derived: sum of 4 quarters · filed 2013-08-20 |
| 2012-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-06 | 2.00M shares derived: sum of 4 quarters · filed 2013-08-20 |
| 2012-09-30 | 1.00M shares 10-Q · filed 2012-11-09 | 2.50M shares derived: sum of 4 quarters · filed 2013-08-20 |
| 2012-06-30 | 600.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-20 | 2.00M shares 10-K · filed 2013-08-20 |
| 2012-03-31 | 400.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-08 | |
| 2011-12-31 | 500.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-07 | |
| 2011-09-30 | 500.00K shares 10-Q · filed 2011-11-04 | |
| 2011-06-30 | 3.00M shares 10-K · filed 2012-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |